Get the Stockscreener App
2.99
1.64%
-0.05
After Hours:
2.97
-0.02
-0.67%
Oncology Institute Inc stock is traded at $2.99, with a volume of 1.38M.
It is down -1.64% in the last 24 hours and up +54.12% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
See More
Previous Close:
$3.04
Open:
$3.13
24h Volume:
1.38M
Relative Volume:
1.34
Market Cap:
$266.68M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-3.7848
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
+6.79%
1M Performance:
+54.12%
6M Performance:
+1,561%
1Y Performance:
+344.15%
1-Day Range:
$2.80
$3.1459
1-Week Range:
$2.26
$3.33
52-Week Range:
$0.1253
$3.50
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
2.99 | 245.73M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
387.52 | 85.09B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
165.47 | 13.82B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
120.87 | 11.73B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
197.94 | 11.71B | 16.08B | 1.20B | 1.06B | 17.82 |
|
DVA
Davita Inc
|
145.41 | 10.86B | 12.82B | 936.34M | 1.47B | 10.74 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
Oncology Institute Inc Stock (TOI) Latest News
BTIG Research Begins Coverage on Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG Initiates Coverage on Oncology Institute (TOI) with Enthusi - GuruFocus
Oncology Institute’s Earnings Call: Strong Start to 2025 - TipRanks
Oncology Institute Narrows Q1 Loss, Reaffirms 2025 Outlook On Capitation And Pharmacy Growth - Nasdaq
BTIG sets $7 price target on The Oncology Institute stock By Investing.com - Investing.com Nigeria
BTIG Initiates Oncology Institute at Buy With $7 Price Target - marketscreener.com
BTIG sets $7 price target on The Oncology Institute stock - Investing.com
BTIG Initiates Coverage on Oncology Institute (TOI) with Enthusiastic Outlook | TOI Stock News - GuruFocus
The Oncology Institute’s Strong Q1 2025 Performance - TipRanks
Earnings call transcript: Oncology Institute Q1 2025 results show revenue growth By Investing.com - Investing.com South Africa
The Oncology Institute (TOI) Reports Q1 Earnings and Revenue Inc - GuruFocus
Earnings call transcript: Oncology Institute Q1 2025 results show revenue growth - Investing.com Australia
Oncology Institute Q1 2025 Earnings Call Transcript - MarketBeat
The Oncology Institute, Inc. Reports Strong Q1 2025 Financial Results and Strategic Growth Initiatives - Nasdaq
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer - The Manila Times
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year ... - Bluefield Daily Telegraph
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - GlobeNewswire
The Oncology Institute Taps Former Cigna National Oncology Director to Scale Value-Based Care Model - Stock Titan
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference - The Manila Times
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional ... - Eagle-Tribune
Leading Value-Based Oncology Group TOI Executives to Share Growth Strategy at B. Riley Conference - Stock Titan
Oncology Institute reports annual meeting outcomes By Investing.com - Investing.com Nigeria
The Oncology Institute to Present at Upcoming ASCO Annual - GlobeNewswire
Oncology Institute Holds Annual Stockholders Meeting - TipRanks
Oncology Institute reports annual meeting outcomes - Investing.com
Oncology Institute (TOI) Highlights Benefits of High-Value Cance - GuruFocus
Oncology Institute (TOI) Highlights Benefits of High-Value Cancer Care Model | TOI Stock News - GuruFocus
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates - marketscreener.com
Renaissance Technologies LLC Grows Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
Oncology Institute COO Jeremy Castle Resigns - TipRanks
The Oncology Institute: Insiders Buy Up Big While Valuations Are Murky (NASDAQ:TOI) - Seeking Alpha
The Oncology Institute, Inc.'s (NASDAQ:TOI) largest shareholders are retail investors with 40% ownership, private equity firms own 24% - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Shares Sold by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
New Outlook On Oncology Institute Inc - Stocksregister
Oncology Institute Inc [TOI] Records 50-Day SMA of $1.38 - knoxdaily.com
A new trading data show Oncology Institute Inc (TOI) is showing positive returns. - Sete News
Closing Strong: Oncology Institute Inc (TOI) Ends at 2.50, Down -14.09 from Last Close - DWinneX
Why The Oncology Institute, Inc. (TOI) is Surging in 2025 - Insider Monkey
Oncology Institute Inc Inc. (TOI) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
Oncology Institute Inc (TOI)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Jefferies gives a Buy recommendation for Oncology Institute Inc (TOI) - knoxdaily.com
Oncology Institute Inc [TOI] Records 50-Day SMA of $1.19 - knoxdaily.com
Take off with Oncology Institute Inc (TOI): Get ready for trading - Sete News
Major Blood Cancer Center Joins CERo's Novel AML Treatment Trial, June Dosing Planned - Stock Titan
Stock Performance Spotlight: Oncology Institute Inc (TOI) Ends the Day at 2.88, Up by 6.27 - DWinneX
Oncology Institute (NASDAQ:TOI) Stock Price Up 6.3% – Still a Buy? - Defense World
The Oncology Institute Reports Third Quarter 2024 Financial Results - ADVFN
The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call - The Manila Times
Leading US Oncology Group TOI Readies Q1 2025 Financial Results: Key Details for May 14 Earnings Call - Stock Titan
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):